MedPath

Modelling Tau Distribution From DTI With Generative Adversarial Network for Alzheimer's Disease Diagnosis

Recruiting
Conditions
Alzheimer's Disease Diagnosis
Registration Number
NCT05020626
Lead Sponsor
Chinese University of Hong Kong
Brief Summary

The most significant impact of this project is to propose for the first time a novel generative adversarial network (GAN), as one kind of deep learning architecture, to automatically generate synthetic PET images reflecting tau deposition, from brain DTI images. If successful, this framework will become the most state-of-the-art approach to simulate the stereotypical pattern of intracerebral tau accumulation and distribution in vivo.

Synthetic tau-PET images via DTI, possessing overwhelming superiority in radiation-free, non-invasiveness and cost-effectiveness, will potentially serve as one of alternative modalities of PET in detecting tau-load and probably outperform PET on accessibility, generalizability, and availability in future, making it much more attractive in clinical application. A big conceptual shift may occur preferring a fire-new tau-PET simulated via DTI.

The DTI data-driven deep learning framework to be created in this project will constitute an accurate, robust, clinically applicable and explainable tool to efficiently categorize the subjects into tau-burden positive and tau-burden negative cases, which will undoubtedly contribute to both clinical and research activities.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
250
Inclusion Criteria
  • With the age of 55 years and above
  • With brain MRI taken within ±6 months from the date of clinically confirmed diagnosis of AD, MCI or normal cognition.
Read More
Exclusion Criteria
  • AD with mixed dementia
  • Non-AD dementia
  • History of severe traumatic brain injury, severe depression, stroke, brain tumors, and incident major systemic illness
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Structural similarity index to measure the similarity between synthetic image and ground truth for 20% of data in testing setThrough study completion, an average of 1 year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The Chinese University of Hong Kong, Prince of Wale Hospital

🇭🇰

Hong Kong, Shatin, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath